Kadimastem laboratory Photo: Kadimastem Kadimastem seeks Nasdaq listing, raises $3.2m from ILEX

The investment will finance clinical development of AstroRx for the treatment of ALS and to begin the clinical development of IsletRx, as a cure for insulin-dependent diabetes.

Perrigo on the NYSE Photo: PR Perrigo to delist from TASE

Perrigo is delisting its shares from the TASE after divesting its Israeli-based operations earlier this year.

Sonovia mask Photo: Company website Sonovia wins mask deal from major aircraft manufacturer

The Israeli company's masks include treated fabric with a very high effectiveness level in neutralizing the Covid pandemic's Delta variant.

Yair Golan  credit: Oron Ben Hakun Israel to have new work safety authority

To fix Israel's atrocious record, Deputy Minister of the Economy Yair Golan is promoting a single authority covering all aspects of safety at work.

Warren Buffett Photo: ASAP Creative Buffett still losing heavily on Teva investment

Berkshire Hathaway is down an estimated $350 million 'on paper' on its investment in Teva.

Zeev Rotstein Photo: Eyal Izhar Former Hadassah chief joins tumor treatment startup

Former Hadassah Hospital CEO Zeev Rotstein has joined the board of Israeli solid tumor treatment startup New Phase.

Big pharma finds Israel's drug development role

AION Labs will set Israeli computing talent to solving international pharma companies' problems. CEO Mati Gill and adviser Christian Tidona explain.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018